ELEVIDYS for treatment of Duchenne muscular dystrophy
Tradename: ELEVIDYS Proper Name: delandistrogene moxeparvovec-rokl Indication: Indicated for treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the…